News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,872 Results
Type
Article (8064)
Company Profile (140)
Press Release (477667)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166781)
Career Advice (316)
Deals (25744)
Drug Delivery (7)
Drug Development (52892)
Employer Resources (14)
FDA (9763)
Job Trends (8579)
News (238283)
Policy (17924)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33162)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (277)
Approvals (10398)
Artificial intelligence (326)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6961)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (18)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3723)
Cardiovascular disease (225)
Career advice (251)
Career pathing (1)
CAR-T (177)
CDMO (11)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (48003)
Collaboration (1272)
Commercialization (3)
Compensation (1519)
Complete response letters (34)
COVID-19 (759)
CRISPR (64)
C-suite (790)
Cystic fibrosis (86)
Data (5808)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4202)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73744)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88053)
Executive appointments (711)
FDA (12455)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (937)
Gene editing (126)
Generative AI (9)
Gene therapy (330)
GLP-1 (294)
Government (947)
Grass and pollen (2)
Guidances (281)
Healthcare (9367)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (949)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (45)
IPO (12387)
IRA (2)
Job creations (1969)
Job search strategy (241)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5195)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (521)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (555)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8675)
Medtech (8830)
Mergers & acquisitions (14403)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1852)
NextGen: Class of 2026 (3151)
Non-profit (844)
Obesity (227)
Opinion (11)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (523)
Patient selection (1)
Peanut (31)
People (41332)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15507)
Phase 2 (21432)
Phase 3 (14459)
Pipeline (7603)
Policy (18)
Postmarket research (1570)
Preclinical (6550)
Press Release (34)
Prostate cancer (194)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (583)
Real estate (3024)
Recruiting (6)
Regulatory (14909)
Reports (23)
Research institute (584)
Resumes & cover letters (47)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (18)
Weight loss (74)
Women's health (83)
Date
Today (52)
Last 7 days (372)
Last 30 days (1444)
Last 365 days (19046)
2026 (13340)
2025 (19257)
2024 (22993)
2023 (26543)
2022 (34601)
2021 (37185)
2020 (33485)
2019 (23285)
2018 (17469)
2017 (18765)
2016 (17924)
2015 (24266)
2014 (21682)
2013 (18140)
2012 (20221)
2011 (20442)
2010 (20334)
Location
Africa (228)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17955)
Australia (2108)
California (12274)
Canada (3218)
China (539)
Colorado (491)
Connecticut (424)
Delaware (211)
Europe (24696)
Florida (1840)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (719)
India (52)
Indiana (320)
Iowa (16)
Japan (416)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1223)
Massachusetts (8055)
Michigan (312)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2677)
New Mexico (12)
New York (2878)
North Carolina (1311)
North Dakota (4)
Northern California (6169)
Ohio (288)
Oklahoma (14)
Oregon (18)
Pennsylvania (2289)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5105)
Tennessee (122)
Texas (1990)
United States (39783)
Utah (367)
Vermont (1)
Virginia (157)
Washington D.C. (38)
Washington State (954)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,872 Results for "macrogenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
MacroGenics is selling the manufacturing plant to Bora, a Taiwan-based CDMO, to raise cash to support the progress of its drug development pipeline.
May 13, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
·
1 min read
Press Releases
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
August 13, 2026
·
12 min read
Regulatory
Patient Death Forces Partial Freeze on MacroGenics’ Gynecologic Cancer Study
A trial of a MacroGenics’ drug temporarily paused enrollment after several safety events, including a fatality. The deceased patient had developed a severe case of neutropenia and concurrent septic shock.
February 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
July 24, 2026
·
7 min read
Press Releases
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
July 2, 2026
·
5 min read
Press Releases
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
August 11, 2026
·
4 min read
Press Releases
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
June 23, 2026
·
6 min read
Press Releases
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
May 12, 2026
·
6 min read
Press Releases
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
May 14, 2026
·
1 min read
1 of 48,588
Next
